ETFs
B
BIIB
Biogen Inc
199.96
+5.72+2.94%After Hours: 198.52 -1.44 -0.72%19:22 06/11 EDT
OPEN/PREV CLOSE195.49/194.24
TODAY RANGE194.24-201.18
VOL33
MARKET CAP29.52B
52 WEEK RANGE121.05-205.97
AVG VOL (3M)1.17M
% TURNOVER0.62%
TURNOVER176.53M
P/E (TTM)21.46
% RANGE3.57%
EPS(TTM)9.32
P/E(FORWARD)22.62
P/B1.582
BVPS126.37
DIVIDEND--
P/S2.966
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP29.45B
SHARES OUTSTANDING147.64M
NEXT EARNINGS07/29-08/03
FREE FLOAT147.28M
LOT SIZE1
EX-DATE02/02/2017
News
Press Releases
Financial Reports
Profile
Simply Wall St·22h ago
Did FDA Breakthrough Status for Salanersen Just Shift Biogen's (BIIB) Long-Term SMA Strategy?
Benzinga·1d ago
Congresswoman Who Bought No Stocks In 2025 Is Back With More 2026 Trades: Here's The Shopping List
TipRanks·1d ago
Biogen Shareholders Back Board, Auditor and Pay Policies
Dow Jones·3d ago
Biogen Price Target Announced at $255.00/Share by Needham
Dow Jones·3d ago
Biogen Raised to Buy From Hold by Needham
TipRanks·3d ago
Biogen upgraded to Buy from Hold at Needham
Benzinga·3d ago
Needham Upgrades Biogen to Buy, Announces $255 Price Target
Reuters·3d ago
BIOGEN <BIIB.O>: NEEDHAM RAISES TO BUY FROM HOLD
Same Industry
Name/Symbol
Change%
Price